Spironolactone Tablet
Product Images NDC 63629-8539

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 63629-8539). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Spironolactone 01)

FDA Label Image

Figure 1 (Spironolactone 02)

FDA Label Image

Figure 2 (Spironolactone 03)

Figure 2 (Spironolactone 03)
This appears to be a medical chart with headings for various tests and medications related to diabetes. There are indications for subgroup, diabetes, and creatinine levels, as well as measurements for potassium and beta blockers. A graph is also present comparing spironolactone and placebo effectiveness.*
FDA Label Image

Label (Lbl636298539)

Label (Lbl636298539)
The text describes information related to Spironolactone Tablets, USP. Each tablet contains 25 mg of Spironolactone USP. The medication should be kept away from the reach of children and stored in a tight, light-resistant container at a temperature range of 20° to 25°C. It should be dispensed only on a prescription by a healthcare professional.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.